Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsInventoryLand & ImprovementsLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aemetis (AMTX) Cash & Equivalents (2016 - 2025)

Historic Cash & Equivalents for Aemetis (AMTX) over the last 14 years, with Q3 2025 value amounting to $5.6 million.

  • Aemetis' Cash & Equivalents rose 178648.65% to $5.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $5.6 million, marking a year-over-year increase of 178648.65%. This contributed to the annual value of $898000.0 for FY2024, which is 6632.92% down from last year.
  • Latest data reveals that Aemetis reported Cash & Equivalents of $5.6 million as of Q3 2025, which was up 178648.65% from $1.6 million recorded in Q2 2025.
  • Over the past 5 years, Aemetis' Cash & Equivalents peaked at $15.8 million during Q1 2021, and registered a low of $234000.0 during Q2 2024.
  • Its 5-year average for Cash & Equivalents is $3.9 million, with a median of $3.5 million in 2022.
  • Its Cash & Equivalents has fluctuated over the past 5 years, first soared by 798734.18% in 2021, then tumbled by 9607.14% in 2022.
  • Quarter analysis of 5 years shows Aemetis' Cash & Equivalents stood at $7.8 million in 2021, then tumbled by 44.36% to $4.3 million in 2022, then crashed by 38.16% to $2.7 million in 2023, then tumbled by 66.33% to $898000.0 in 2024, then skyrocketed by 521.83% to $5.6 million in 2025.
  • Its Cash & Equivalents was $5.6 million in Q3 2025, compared to $1.6 million in Q2 2025 and $499000.0 in Q1 2025.